14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:PTLA
Delisted

Portola Pharmaceuticals Stock Predictions

NASDAQ Stock Exchange
Open Broker Account
$18.03
+0 (+0%)
At Close: Sep 04, 2020
Forecast Insider Trading Signals Historical Prices Predictions Profile
Currently predicting for Mon, 20 May 2024

PTLA Predictions History

5 years ago
 StormS predicted that PTLA for 2018-09-13 is going $29.51 (1.30%)

Rank:

7 years ago
 Bradley.Squad.2021 predicted that PTLA for 2016-12-28 is going $15.57 (-31.65%)

Rank:
Click to get the best stock tips daily for free!

About Portola Pharmaceuticals

Portola Pharmaceuticals Portola Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics for patients in the areas of thrombosis, other hematologic disorders, and inflammation. The company is developing Betrixaban, an oral, once-daily Factor Xa inhibitor, which is in Phase III clinical trial for treating venous thromboembolism prophylaxis in acute medically ill patients in-hospital and post discharge; and Andexanet alfa, a recombinant... PTLA Profile

Golden Star

Ticker Date Change Price
LYV May 15 0.114% $96.48
RL May 15 0.539% $166.98
PAGS May 15 0.157% $12.74
EVBG May 15 0.230% $34.79
INBX May 15 0.96% $34.37
CME May 14 1.11% $210.80
VGIT May 14 0.173% $57.83
VCLT May 14 0.726% $75.73
BNDX May 14 0.267% $48.60
FIXD May 14 0.303% $42.89
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT